OncoSec Medical Hosting SITC Key Opinion Leader Webinar on Updated Data from the KEYNOTE-695 Study Nov 02, 2021 8:00am EDT
OncoSec to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference Jul 26, 2021 8:30am EDT
OncoSec Enters into a Collaboration Agreement with Merck for a Pivotal Global Phase 3 Study, KEYNOTE-C87, of TAVO™ Combined with KEYTRUDA® for Late-Stage Metastatic Melanoma Jul 06, 2021 4:01pm EDT
OncoSec Appoints Industry Leading Electroporation Device Expert, Jeffrey Silverman, as Vice President of Product Engineering Jun 14, 2021 8:30am EDT
OncoSec Appoints Robert M. Schinagl, Ph.D. as Vice President of Program and Alliance Management May 17, 2021 8:30am EDT
